Koos De Wit - Publications

Comparative performance of HCC risk scores in identifying low-risk patients with cirrhosis: A multicenter cohort study.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: May 19, 2026

Antibiotic Prophylaxis in Patients With Cirrhosis Presenting With Variceal Bleeding-Are We Treating the Past?

Journal: JAMA internal medicine

Published: November 17, 2025

Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial.

Journal: JAMA

Published: February 05, 2025

Increase in prevalence and costs of cirrhosis in the Netherlands: a nationwide hospital diagnosis data analysis.

Journal: European journal of gastroenterology & hepatology

Published: December 11, 2024

Rifaximin-α in Patients With Recurrent Episodes of Hepatic Encephalopathy Due to Cirrhosis Reduces Healthcare Utilization.

Journal: United European gastroenterology journal

Published: September 05, 2024

Neurofilament light chain but not glial fibrillary acidic protein is a potential biomarker of overt hepatic encephalopathy in patients with cirrhosis.

Journal: Annals of hepatology

Published: September 20, 2023

Novel prognostic biomarkers in decompensated cirrhosis: a systematic review and meta-analysis.

Journal: Gut

Published: March 22, 2023

Decompensation as initial presentation in patients with liver cirrhosis is associated with an increased risk of future decompensation and mortality.

Journal: Scandinavian journal of gastroenterology

Published: February 10, 2023

Opt-In and Opt-Out Consent Procedures for the Reuse of Routinely Recorded Health Data in Scientific Research and Their Consequences for Consent Rate and Consent Bias: Systematic Review.

Journal: Journal of medical Internet research

Published: August 25, 2022

Rifaximin stimulates nitrogen detoxification by PXR-independent mechanisms in human small intestinal organoids.

Journal: Liver international : official journal of the International Association for the Study of the Liver

Published: August 18, 2022

Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis.

Journal: Hepatology communications

Published: May 28, 2021

Doppler follow-up after TIPS placement is not routinely indicated. A 16-years single centre experience.

Journal: The Netherlands journal of medicine

Published: December 31, 2020